Rocket Lab Corporation $RKLB Shares Bought by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management increased its stake in Rocket Lab (NASDAQ:RKLB) by 188.7% in Q4 to 20,876 shares, worth about $1.456M, and institutional investors now own roughly 71.78% of the stock.
• Analysts give Rocket Lab a consensus rating of Moderate Buy with a consensus price target of $81.77, amid mixed re-ratings and target changes from several firms.
• Insider selling is notable—CEOs and senior officers have sold a combined 233,449 shares (~$16.49M) in the past 90 days—while operational positives (backlog above $2B, Mynaric acquisition close, new Gauss thruster) improve revenue visibility but raise valuation and execution concerns.

Robeco Institutional Asset Management B.V. boosted its position in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 188.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,876 shares of the rocket manufacturer's stock after acquiring an additional 13,644 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Rocket Lab were worth $1,456,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC acquired a new position in Rocket Lab during the 4th quarter worth approximately $25,000. V Square Quantitative Management LLC acquired a new position in Rocket Lab during the 4th quarter worth approximately $32,000. Wilmington Savings Fund Society FSB acquired a new position in Rocket Lab during the 3rd quarter worth approximately $25,000. Hara Capital LLC acquired a new position in Rocket Lab during the 3rd quarter worth approximately $25,000. Finally, Tema Etfs LLC acquired a new position in Rocket Lab during the 4th quarter worth approximately $38,000. Institutional investors and hedge funds own 71.78% of the company's stock.

Analysts Set New Price Targets

Several research firms have commented on RKLB. Wall Street Zen upgraded shares of Rocket Lab from a "sell" rating to a "hold" rating in a report on Sunday, February 8th. Needham & Company LLC lowered their price target on shares of Rocket Lab from $110.00 to $95.00 and set a "buy" rating for the company in a report on Friday, February 27th. Cantor Fitzgerald reiterated an "overweight" rating and set a $85.00 price target on shares of Rocket Lab in a report on Friday, March 13th. KeyCorp cut shares of Rocket Lab from an "overweight" rating to a "sector weight" rating in a report on Thursday, January 15th. Finally, Stifel Nicolaus boosted their price target on shares of Rocket Lab from $75.00 to $85.00 and gave the stock a "buy" rating in a report on Monday, December 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Rocket Lab presently has a consensus rating of "Moderate Buy" and a consensus price target of $81.77.

Rocket Lab Stock Up 2.3%

Shares of NASDAQ:RKLB opened at $84.80 on Friday. The company has a market capitalization of $48.29 billion, a PE ratio of -229.18 and a beta of 2.20. The company has a current ratio of 4.08, a quick ratio of 3.61 and a debt-to-equity ratio of 0.10. Rocket Lab Corporation has a twelve month low of $18.21 and a twelve month high of $99.58. The firm has a 50 day simple moving average of $70.03 and a 200-day simple moving average of $66.60.

Insider Buying and Selling at Rocket Lab

In other news, CFO Adam C. Spice sold 62,744 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $69.59, for a total transaction of $4,366,354.96. Following the completion of the sale, the chief financial officer owned 1,296,824 shares in the company, valued at approximately $90,245,982.16. The trade was a 4.61% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Peter Beck sold 18,857 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $69.59, for a total transaction of $1,312,258.63. Following the sale, the chief executive officer owned 884,085 shares of the company's stock, valued at $61,523,475.15. This represents a 2.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 233,449 shares of company stock worth $16,487,233. 11.90% of the stock is owned by insiders.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Defense contracts and backlog growth boost revenue visibility — Rocket Lab disclosed multi‑launch awards (including new hypersonic HASTE work) and expanded manifests that lift its multi‑year backlog above $2B, underpinning near‑term revenue and investor confidence. RKLB jumps 8% as contract momentum and fresh analyst optimism lift sentiment
• Positive Sentiment: Mynaric acquisition closes — adds laser optical communications, an operational foothold in Europe, and cross‑sell opportunities for commercial and national‑security customers, expanding Rocket Lab’s TAM beyond launch and propulsion. Rocket Lab’s Mynaric Deal Adds Growth Angle In Europe And Valuation Risks
• Positive Sentiment: Gauss thruster debut — unveiling a scalable Hall‑thruster line (targeting >200 units/year) strengthens Rocket Lab’s in‑house propulsion capability and supports recurring revenue for satellite constellations and national‑security programs. Rocket Lab (RKLB) Is Up 6.5% After Unveiling High‑Volume Gauss Propulsion Line For Satellite Constellations
• Neutral Sentiment: Analyst updates and options activity are amplifying the move — several firms have issued bullish notes or higher targets and unusually high call option volume has coincided with the rally, which can accelerate short‑term price moves but also increase volatility. Zacks Investment Ideas feature highlights: Rocket Lab
• Neutral Sentiment: Upcoming earnings date (Q1 2026 results scheduled for May 7) creates a near‑term catalyst — results and guidance will be closely watched for revenue conversion from backlog and margin progress. Rocket Lab Announces Date of First-Quarter 2026 Financial Results
• Negative Sentiment: Significant insider selling is a red flag for some investors — multiple executives (including the CEO and senior officers) have executed large sales recently, which can weigh on sentiment despite operational positives. RKLB jumps 8% as contract momentum and fresh analyst optimism lift sentiment (insider details)
• Negative Sentiment: Valuation and execution risk remain — coverage notes raise caution about elevated valuation and integration/scale risks from acquisitions and rapid product rollouts; investors should weigh growth expectations against a large market cap and negative GAAP profitability. Rocket Lab’s Mynaric Deal Adds Growth Angle In Europe And Valuation Risks

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.